NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

CompletedPhase 4

Sponsor: Yale University

Conditions: Tobacco Use Cessation

Interventions: Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler, Varenicline or bupropion, Contingency Management

Countries: United States

Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a group of PLWH.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* HIV positive;
* \>= 18 years old
* Receiving HIV care at Yale-New Haven Hospital, Bridgeport Hospital, Mount Sinai Hospital, or SUNY Downstate STAR clinic;
* Have smoked \>= 100 cigarettes in lifetime;
* Currently smokes some days or every day;
* Smokes, on average, \>= 5 cigarettes per day;
* Able to provide written informed consent.

Exclusion Criteria:

* Using only non-cigarette nicotine products (i.e., e-cigs, Juul, etc.);
* Currently using NRT, VAR, or bupropion (defined as use in the prior 7 days);
* Self-report or urine testing confirming pregnancy, nursing, or trying to conceive;
* Life-threatening or unstable medical, surgical, or psychiatric condition;
* Inability to provide at least one collateral contact (family member or friend);
* Living out of state;
* Unable to read or understand English (except at Mount Sinai site).

Locations (4)

Bridgeport, Connecticut, United States
New Haven, Connecticut, United States
Brooklyn, New York, United States
New York, New York, United States